{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:45:45Z","timestamp":1785321945062,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences, Mental Health and Addiction","doi-asserted-by":"publisher","award":["FDN148397"],"award-info":[{"award-number":["FDN148397"]}],"id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000034","name":"Institute of Neurosciences, Mental Health and Addiction","doi-asserted-by":"publisher","award":["10677"],"award-info":[{"award-number":["10677"]}],"id":[{"id":"10.13039\/501100000034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002736","name":"Citizens United for Research in Epilepsy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1UG3NS123958-01"],"award-info":[{"award-number":["1UG3NS123958-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0930"],"award-info":[{"award-number":["W81XWH-20-1-0930"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9425-23-1-0330"],"award-info":[{"award-number":["HT9425-23-1-0330"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial hemiplegic migraine type-1 (FHM-1) is a form of migraine with aura caused by mutations in the P\/Q-type (Cav2.1) voltage-gated calcium channel. Pregabalin, used clinically in the treatment of chronic pain and epilepsy, inhibits P\/Q-type calcium channel activity and recent studies suggest that it may have potential for the treatment of migraine. Spreading Depolarization (SD) is a neurophysiological phenomenon that can occur during migraine with aura by propagating a wave of silenced neuronal function through cortex and sometimes subcortical brain structures. Here, utilizing an optogenetic stimulation technique optimized to allow for non-invasive initiation of cortical SD, we demonstrate that chronic pregabalin administration [12\u00a0mg\/kg\/day (s.c.)] in vivo increased the threshold for cortical spreading depolarization in transgenic mice harboring the clinically-relevant Ca<jats:sub>v<\/jats:sub>2.1<jats:sup>S218L<\/jats:sup> mutation (S218L). In addition, chronic pregabalin treatment limited subcortical propagation of recurrent spreading depolarization events to the striatum and hippocampus in both wild-type and S218L mice. To examine contributing underlying mechanisms of action of chronic pregabalin, we performed whole-cell patch-clamp electrophysiology in CA1 neurons in ex vivo brain slices from mice treated with chronic pregabalin vs vehicle. In WT mice, chronic pregabalin produced a decrease in spontaneous excitatory postsynaptic current (sEPSC) amplitude with no effect on frequency. In contrast, in S218L mice chronic pregabalin produced an increase in sEPSC amplitude and decreased frequency. These electrophysiological findings suggest that in FHM-1 mice chronic pregabalin acts through both pre- and post-synaptic mechanisms in CA1 hippocampal neurons to elicit FHM-1 genotype-specific inhibitory action. The results highlight the potential of chronic pregabalin to limit recurrent SD to subcortical brain structures during pathophysiological events in both the genetically-normal and FHM-1 brain. The work further provides insights into FHM-1 pathophysiology and the potential for chronic pregabalin treatment to prevent SD in migraineurs.<\/jats:p>","DOI":"10.1186\/s13041-023-01062-6","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T12:02:42Z","timestamp":1699012962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chronic pregabalin treatment protects against spreading depolarization and alters hippocampal synaptic characteristics in a model of familial hemiplegic migraine-type 1"],"prefix":"10.1186","volume":"16","author":[{"given":"Stuart M.","family":"Cain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha R. A.","family":"Alles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Gopaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Philippe","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"MacVicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-1296","authenticated-orcid":false,"given":"Terrance P.","family":"Snutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"1062_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fncel.2020.00083\/full","volume":"14","author":"SRA Alles","year":"2020","unstructured":"Alles SRA, Cain SM, Snutch TP. Pregabalin as a pain therapeutic: beyond calcium channels. Front Cell Neurosci. 2020;14:83. https:\/\/doi.org\/10.3389\/fncel.2020.00083\/full.","journal-title":"Front Cell Neurosci"},{"key":"1062_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6:108\u201313.","journal-title":"Curr Opin Pharmacol"},{"key":"1062_CR3","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1073\/pnas.0708930105","volume":"105","author":"J Hendrich","year":"2008","unstructured":"Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, et al. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci USA. 2008;105:3628\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1062_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4161\/chan.2.1.6045","volume":"2","author":"F Heblich","year":"2008","unstructured":"Heblich F, Van Minh AT, Hendrich J, Watschinger K, Dolphin AC. Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin. Channels Austin Tex. 2008;2:4\u20139.","journal-title":"Channels Austin Tex"},{"key":"1062_CR5","doi-asserted-by":"publisher","first-page":"12856","DOI":"10.1523\/JNEUROSCI.2700-10.2010","volume":"30","author":"A Tran-Van-Minh","year":"2010","unstructured":"Tran-Van-Minh A, Dolphin AC. The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2. J Neurosci Off J Soc Neurosci. 2010;30:12856\u201367.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1062_CR6","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.1073\/pnas.1403731111","volume":"111","author":"JS Cassidy","year":"2014","unstructured":"Cassidy JS, Ferron L, Kadurin I, Pratt WS, Dolphin AC. Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary \u03b12\u03b4-1 subunits. Proc Natl Acad Sci USA. 2014;111:8979\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1062_CR7","doi-asserted-by":"publisher","first-page":"174480691876580","DOI":"10.1177\/1744806918765806","volume":"14","author":"SR Alles","year":"2018","unstructured":"Alles SR, Garcia E, Balasubramanyan S, Jones K, Tyson JR, Joy T, et al. Peripheral nerve injury increases contribution of L-type calcium channels to synaptic transmission in spinal lamina II: Role of \u03b12\u03b4\u20131 subunits. Mol Pain. 2018;14:174480691876580. https:\/\/doi.org\/10.1177\/1744806918765806.","journal-title":"Mol Pain"},{"issue":"33","key":"1062_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"2013","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2023","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2023;2013(33):629\u2013808. https:\/\/doi.org\/10.1177\/0333102413485658.","journal-title":"Cephalalgia"},{"key":"1062_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00019\/full","author":"O Cozzolino","year":"2018","unstructured":"Cozzolino O, Marchese M, Trovato F, Pracucci E, Ratto GM, Buzzi MG, et al. Understanding spreading depression from headache to sudden unexpected death. Front Neurol. 2018. https:\/\/doi.org\/10.3389\/fneur.2018.00019\/full.","journal-title":"Front Neurol"},{"key":"1062_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1152\/physrev.00027.2014","volume":"95","author":"C Ayata","year":"2015","unstructured":"Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiol Rev. 2015;95:953\u201393.","journal-title":"Physiol Rev"},{"key":"1062_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nm.2333","volume":"17","author":"JP Dreier","year":"2011","unstructured":"Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 2011;17:439\u201347.","journal-title":"Nat Med"},{"key":"1062_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jcbfm.2010.191","volume":"31","author":"M Lauritzen","year":"2011","unstructured":"Lauritzen M, Dreier JP, Fabricius M, Hartings JA, Graf R, Strong AJ. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2011;31:17\u201335.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"1062_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.bbamem.2012.11.012","volume":"1828","author":"D Pietrobon","year":"2013","unstructured":"Pietrobon D. Calcium channels and migraine. Biochim Biophys Acta. 2013;1828:1655\u201365.","journal-title":"Biochim Biophys Acta"},{"key":"1062_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0896-6273(04)00085-6","volume":"41","author":"AM van den Maagdenberg","year":"2004","unstructured":"van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41:701\u201310.","journal-title":"Neuron"},{"key":"1062_CR15","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1073\/pnas.192242399","volume":"99","author":"A Tottene","year":"2002","unstructured":"Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, et al. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA. 2002;99:13284\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1062_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.21815","volume":"67","author":"AM van den Maagdenberg","year":"2010","unstructured":"van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol. 2010;67:85\u201398.","journal-title":"Ann Neurol"},{"key":"1062_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/awy325","volume":"142","author":"ICM Loonen","year":"2019","unstructured":"Loonen ICM, Jansen NA, Cain SM, Schenke M, Voskuyl RA, Yung AC, et al. Brainstem spreading depolarization and cortical dynamics during fatal seizures in Cacna1a S218L mice. Brain J Neurol. 2019;142:412\u201325.","journal-title":"Brain J Neurol"},{"key":"1062_CR18","first-page":"783","volume":"17","author":"O Hesami","year":"2018","unstructured":"Hesami O, Shams MR, Ayazkhoo L, Assarzadegan F, Safarpour Lima B, Delavar Kasmaei H, et al. Comparison of pregabalin and sodium valproate in migraine prophylaxis: a randomized double-blinded study. Iran J Pharm Res IJPR. 2018;17:783\u20139.","journal-title":"Iran J Pharm Res IJPR"},{"key":"1062_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/WNF.0b013e3181bf1dbe","volume":"33","author":"EP Calandre","year":"2010","unstructured":"Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Vilchez JS, Rodriguez-Lopez CM. Pregabalin in the treatment of chronic migraine: an open-label study. Clin Neuropharmacol. 2010;33:35\u20139.","journal-title":"Clin Neuropharmacol"},{"key":"1062_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10194-011-0338-0","volume":"12","author":"R Pizzolato","year":"2011","unstructured":"Pizzolato R, Villani V, Prosperini L, Ciuffoli A, Sette G. Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study. J Headache Pain. 2011;12:521\u20135.","journal-title":"J Headache Pain"},{"key":"1062_CR21","first-page":"276","volume":"53","author":"M Bakhshandeh Bali","year":"2015","unstructured":"Bakhshandeh Bali M, Rahbarimanesh AA, Sadeghi M, Sedighi M, Karimzadeh P, Ghofrani M. Comparison of propranolol and pregabalin for prophylaxis of childhood migraine: a randomised controlled trial. Acta Med Iran. 2015;53:276\u201380.","journal-title":"Acta Med Iran"},{"key":"1062_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1614447114","author":"SM Cain","year":"2017","unstructured":"Cain SM, Bohnet B, LeDue J, Yung AC, Garcia E, Tyson JR, et al. In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures. Proc Natl Acad Sci. 2017. https:\/\/doi.org\/10.1073\/pnas.1614447114.","journal-title":"Proc Natl Acad Sci"},{"key":"1062_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pain.2007.06.033","volume":"136","author":"JH Vranken","year":"2008","unstructured":"Vranken JH, Dijkgraaf MGW, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136:150\u20137.","journal-title":"Pain"},{"key":"1062_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/MJT.0b013e3181d5e4f3","volume":"17","author":"U Sharma","year":"2010","unstructured":"Sharma U, Griesing T, Emir B, Young JP. Time to onset of neuropathic pain reduction: a retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia. Am J Ther. 2010;17:577\u201385.","journal-title":"Am J Ther"},{"key":"1062_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac006","author":"SM Cain","year":"2022","unstructured":"Cain SM, Bernier L-P, Zhang Y, Yung AC, Kass J, Bohnet B, et al. Hyperexcitable superior colliculus and fatal brainstem spreading depolarization in a model of sudden unexpected death in epilepsy. Brain Commun. 2022. https:\/\/doi.org\/10.1093\/braincomms\/fcac006.","journal-title":"Brain Commun"},{"key":"1062_CR26","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1523\/JNEUROSCI.5346-10.2011","volume":"31","author":"K Eikermann-Haerter","year":"2011","unstructured":"Eikermann-Haerter K, Yuzawa I, Qin T, Wang Y, Baek K, Kim YR, et al. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci Off J Soc Neurosci. 2011;31:5755\u201363.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1062_CR27","doi-asserted-by":"publisher","first-page":"17678","DOI":"10.1074\/jbc.M501110200","volume":"280","author":"A Tottene","year":"2005","unstructured":"Tottene A, Pivotto F, Fellin T, Cesetti T, van den Maagdenberg AM, Pietrobon D. Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma. J Biol Chem. 2005;280:17678\u201386.","journal-title":"J Biol Chem"},{"key":"1062_CR28","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1523\/JNEUROSCI.2526-13.2014","volume":"34","author":"MN Di Guilmi","year":"2014","unstructured":"Di Guilmi MN, Wang T, Inchauspe CG, Forsythe ID, Ferrari MD, van den Maagdenberg AMJM, et al. Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i. J Neurosci Off J Soc Neurosci. 2014;34:7047\u201358.","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"1062_CR29","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/pnas.1009500107","volume":"107","author":"PJ Adams","year":"2010","unstructured":"Adams PJ, Rungta RL, Garcia E, van den Maagdenberg AM, Macvicar BA, Snutch TP. Contribution of calcium-dependent facilitation to synaptic plasticity revealed by migraine mutations in the P\/Q-type calcium channel. Proc Natl Acad Sci USA. 2010;107:18694\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1062_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fncel.2015.00008","volume":"9","author":"D Vecchia","year":"2015","unstructured":"Vecchia D, Tottene A, van den Maagdenberg AMJM, Pietrobon D. Abnormal cortical synaptic transmission in CaV2.1 knockin mice with the S218L missense mutation which causes a severe familial hemiplegic migraine syndrome in humans. Front Cell Neurosci. 2015;9:8.","journal-title":"Front Cell Neurosci"},{"key":"1062_CR31","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.1113\/JP283600","volume":"600","author":"KS Pilch","year":"2022","unstructured":"Pilch KS, Ramgoolam KH, Dolphin AC. Involvement of CaV 2.2 channels and \u03b12 \u03b4-1 in homeostatic synaptic plasticity in cultured hippocampal neurons. J Physiol. 2022;600:5333\u201351.","journal-title":"J Physiol"},{"key":"1062_CR32","doi-asserted-by":"publisher","first-page":"12273","DOI":"10.3390\/ijms222212273","volume":"22","author":"L Nie","year":"2021","unstructured":"Nie L, Jiang L, Quinn JP, Grubb BD, Wang M. TRPA1-mediated Src family kinases activity facilitates cortical spreading depression susceptibility and trigeminovascular system sensitization. Int J Mol Sci. 2021;22:12273.","journal-title":"Int J Mol Sci"},{"key":"1062_CR33","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0333102411425865","volume":"31","author":"I Sukhotinsky","year":"2011","unstructured":"Sukhotinsky I, Dilekoz E, Wang Y, Qin T, Eikermann-Haerter K, Waeber C, et al. Chronic daily cortical spreading depressions suppress spreading depression susceptibility. Cephalalgia Int J Headache. 2011;31:1601\u20138.","journal-title":"Cephalalgia Int J Headache"},{"key":"1062_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-022-02596-7","volume":"19","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Jiang J, He Y, Cai J, Xie J, Wu M, et al. Pregabalin mitigates microglial activation and neuronal injury by inhibiting HMGB1 signaling pathway in radiation-induced brain injury. J Neuroinflammation. 2022;19:231.","journal-title":"J Neuroinflammation"},{"key":"1062_CR35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neuropharm.2016.11.011","volume":"113","author":"SRA Alles","year":"2017","unstructured":"Alles SRA, Bandet MV, Eppler K, Noh M-C, Winship IR, Baker G, et al. Acute anti-allodynic action of gabapentin in dorsal horn and primary somatosensory cortex: Correlation of behavioural and physiological data. Neuropharmacology. 2017;113:576\u201390.","journal-title":"Neuropharmacology"},{"key":"1062_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10194-023-01628-8","volume":"24","author":"A Dehghani","year":"2023","unstructured":"Dehghani A, Schenke M, van Heiningen SH, Karatas H, Tolner EA, van den Maagdenberg AMJM. Optogenetic cortical spreading depolarization induces headache-related behaviour and neuroinflammatory responses some prolonged in familial hemiplegic migraine type 1 mice. J Headache Pain. 2023;24:96.","journal-title":"J Headache Pain"},{"key":"1062_CR37","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-021-22464-x","volume":"12","author":"I Tamim","year":"2021","unstructured":"Tamim I, Chung DY, de Morais AL, Loonen ICM, Qin T, Misra A, et al. Spreading depression as an innate antiseizure mechanism. Nat Commun. 2021;12:2206.","journal-title":"Nat Commun"},{"key":"1062_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrn3770","volume":"15","author":"D Pietrobon","year":"2014","unstructured":"Pietrobon D, Moskowitz MA. Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations. Nat Rev Neurosci. 2014;15:379\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"1062_CR39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/36103","volume":"391","author":"GG Turrigiano","year":"1998","unstructured":"Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature. 1998;391:892\u20136.","journal-title":"Nature"},{"key":"1062_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pain.2006.04.022","volume":"125","author":"C-Y Li","year":"2006","unstructured":"Li C-Y, Zhang X-L, Matthews EA, Li K-W, Kurwa A, Boroujerdi A, et al. Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain. 2006;125:20\u201334.","journal-title":"Pain"},{"key":"1062_CR41","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1074\/jbc.M114.548990","volume":"289","author":"K-W Li","year":"2014","unstructured":"Li K-W, Yu YP, Zhou C, Kim D-S, Lin B, Sharp K, et al. Calcium channel \u03b12\u03b41 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis. J Biol Chem. 2014;289:7025\u201337.","journal-title":"J Biol Chem"},{"key":"1062_CR42","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1523\/JNEUROSCI.21-06-01868.2001","volume":"21","author":"ZD Luo","year":"2001","unstructured":"Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, et al. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci Off J Soc Neurosci. 2001;21:1868\u201375.","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"Suppl 6","key":"1062_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.0013-9580.2004.455003.x","volume":"45","author":"E Ben-Menachem","year":"2004","unstructured":"Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45(Suppl 6):13\u20138.","journal-title":"Epilepsia"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-023-01062-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01062-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T12:05:14Z","timestamp":1699013114000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-023-01062-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1062"],"URL":"https:\/\/doi.org\/10.1186\/s13041-023-01062-6","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"25 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed in accordance with the guidelines of the Canadian Council on Animal Care and the University of British Columbia Animal Care Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}